Celltrion
Celltrion develops tailored neutralising antibody cocktail treatment with CT-P59 to tackle COVID-19 variant spread using its antibody development plat.
Rankings by
National Ranking8th
in South Korea Regional Ranking30th
in East Asia Global Ranking812th
worldwide